02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
16,000 nationwide complaints to OSHA agencies since April prompt sector-specific guidance - OSHA co...
Read More >
The title of this post describes not an army maneuver, but the outcome of a recent lawsuit in Delawa...
Read More >
On June 13, 2019, the Eighth Circuit affirmed the district court’s grant of a preliminary injunctio...
Read More >
It appears Oregon will be joining the wave of states enacting laws against hair-based discrimination...
Read More >
USCIS has announced that on January 2, 2020 it will dispose of its E-Verify records for cases that a...
Read More >
Our team of M&A and project finance partners will discuss some key tips in maximizing efficiency in ...
Read More >